Pfizer Recalls 3 Lots of Effexor XR, Generic Equivalent

New York-based Pfizer has issued a recall on three lots of Effexor XR and Greenstone LLC-branded Venlafaxine HC1 capsules because a pharmacist reported finding a Tikosyn (dofetilide) capsule in one bottle of Effexor XR.

Advertisement

The effects and of taking a Tikosyn while also taking Effexor XR could cause serious adverse events, including death, according to the report.

Pharmacists should quarantine and cease distribution of any of the affected lots, and patients who have a potentially affected product should return it to their pharmacy and notify their physician, advises the report.

More Articles on Recalls:

4 Latest Medical Device Recalls
Medisca Recalls L-Citrulline Products, Cites Lack of L-Citrulline
Ben Venue Laboratories Recalls 10% Acetylcysteine Solution

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.